Literature DB >> 25145476

Tumorigenesis: FBP1 is suppressed in kidney tumours.

Gemma K Alderton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25145476     DOI: 10.1038/nrc3810

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Fructose-1,6-bisphosphatase opposes renal carcinoma progression.

Authors:  Bo Li; Bo Qiu; David S M Lee; Zandra E Walton; Joshua D Ochocki; Lijoy K Mathew; Anthony Mancuso; Terence P F Gade; Brian Keith; Itzhak Nissim; M Celeste Simon
Journal:  Nature       Date:  2014-07-20       Impact factor: 49.962

  1 in total
  8 in total

1.  Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis.

Authors:  Jin Dai; Yanli Ji; Wei Wang; Donghern Kim; Leonard Yenwong Fai; Lei Wang; Jia Luo; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-15       Impact factor: 4.219

2.  Increased miR-21a provides metabolic advantages through suppression of FBP1 expression in non-small cell lung cancer cells.

Authors:  Qingchun Dai; Na Li; Xiaohong Zhou
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

3.  Association between FBP1 and hypoxia-related gene expression in clear cell renal cell carcinoma.

Authors:  Xiang-Hui Ning; Teng Li; Yan-Qing Gong; Qun He; Q I Shen; Shuang-He Peng; Jiang-Yi Wang; Jin-Chao Chen; Ying-Lu Guo; Kan Gong
Journal:  Oncol Lett       Date:  2016-04-27       Impact factor: 2.967

4.  Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition.

Authors:  Jing Li; Ying Wang; Qing-Guo Li; Jin-Jun Xue; Zhu Wang; Xin Yuan; Jian-Dong Tong; Li-Chun Xu
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

5.  MAGE-TRIM28 complex promotes the Warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation.

Authors:  X Jin; Y Pan; L Wang; L Zhang; R Ravichandran; P R Potts; J Jiang; H Wu; H Huang
Journal:  Oncogenesis       Date:  2017-04-10       Impact factor: 7.485

Review 6.  Targeting FBPase is an emerging novel approach for cancer therapy.

Authors:  Gao-Min Liu; Yao-Ming Zhang
Journal:  Cancer Cell Int       Date:  2018-03-09       Impact factor: 5.722

7.  Significance of Methylation of FBP1 Gene in Non-Small Cell Lung Cancer.

Authors:  Yao Dong; Sheng Huaying; Wan Danying; Zhu Chihong; Jiang Ruibin; Sun Xiaojiang; Feng Jianguo
Journal:  Biomed Res Int       Date:  2018-06-10       Impact factor: 3.411

8.  Screening common signaling pathways associated with drug resistance in non-small cell lung cancer via gene expression profile analysis.

Authors:  Ting Sun; Qitai Zhao; Chaoqi Zhang; Ling Cao; Mengjia Song; Nomathamsanqa Resegofetse Maimela; Shasha Liu; Jinjin Wang; Qun Gao; Guohui Qin; Liping Wang; Yi Zhang
Journal:  Cancer Med       Date:  2019-04-25       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.